Live stream preview

Next video will start in 30 seconds

Lantern Pharma: AI-Based Drug Discovery and Development Targeting Cancer

Close Open

DSS: Rapid Growth Across Diverse Business Segments

Investing - Small-Cap Market Intelligence • 9m 50s

Up Next in Investing - Small-Cap Market Intelligence

  • Lantern Pharma: AI-Based Drug Discove...

    Lantern Pharma (NASDAQ: LTRN) is a clinical stage biotechnology company focused on leveraging artificial intelligence (“A.I.”), machine learning and genomic data to transform the cost, risk and timeline of oncology drug discovery and development. Lantern utilizes its proprietary RADR® A.I. platfo...

  • Tiziana: Transforming Treatments for ...

    Tiziana Life Sciences (NASDAQ: TLSA; LSE: TILS) is developing targeted therapeutics to transform treatment of liver diseases, inflammatory diseases, and cancer. Our clinical pipeline includes drug assets for Crohn's, and hepatocellular carcinoma. Tiziana’s two lead drug candidates, Foralumab and ...

  • Exclusive interview with Aptorum Grou...

    Exclusive interview with Aptorum Group (NASDAQ: APM) President Darren Lui. Aptorum is a pharmaceutical company dedicated to developing and commercializing novel therapeutics to tackle unmet medical needs. Aptorum's current drug pipeline includes indications in orphan diseases, infectious diseases...